Zenome

Zenome is a genomics and health-data technology organization building a decentralized platform for storage, analysis, exchange, and monetization of genomic information. The company positions its offering as a blockchain-enabled "distributed genomic internet" that gives individuals greater control over access to their DNA and health data through smart contracts and tokenized incentives. In addition to the platform, Zenome has promoted consumer genetic testing and genomic reporting services and has described use cases spanning research, personal genomics, and data sharing with scientific and industry participants. The business appears to be focused more on infrastructure, data exchange, and genomic services than on developing therapeutic drug candidates. Publicly available information indicates an early-stage, privately held, active organization founded in 2017 and based in Moscow.